Ouellet Gregory M, Geda Mary, Murphy Terrence E, Tsang Sui, Tinetti Mary E, Chaudhry Sarwat I
Section of Geriatrics, Department of Medicine, School of Medicine, Yale University, New Haven, Connecticut.
Section of General Internal Medicine, Department of Medicine, School of Medicine, Yale University, New Haven, Connecticut.
J Am Geriatr Soc. 2017 Nov;65(11):2391-2396. doi: 10.1111/jgs.15102. Epub 2017 Oct 18.
BACKGROUND/OBJECTIVES: Timely administration of antiischemic therapies improves outcomes in individuals with acute myocardial infarction (AMI). Prior literature on delays in AMI care has largely focused on in-hospital delay ("door to balloon" time). Our objective was to identify factors associated with prehospital delay in a contemporary national cohort of older adults with AMI.
Cross-sectional analysis of data from the ComprehenSIVe Evaluation of Risk Factors in Older Patients with Acute Myocardial Infarction (SILVER-AMI) study, an observational study of older adults hospitalized for AMI.
U.S. academic and community hospitals (N = 94).
Individuals aged 75 and older hospitalized for AMI (N = 2,500).
Prehospital delay was defined as symptom duration of 6 hours or longer before hospital presentation and was obtained according to participant or caregiver report during AMI hospitalization. Potential predictors of delay from demographic, clinical presentation, comorbid conditions, function, and social support domains were obtained through in-person assessment during the index hospitalization and medical record abstraction.
Nonwhite race (adjusted odds ratio (aOR) = 1.54, P = .002), atypical symptoms (aOR = 1.41, P = .001), and heart failure (HF) (aOR = 1.35, P = .006 for HF) were significantly associated with delay.
In contrast with younger AMI populations, female sex and diabetes mellitus were not associated with delay in this older cohort, but factors from other domains (nonwhite race, atypical symptoms, and HF) were significantly associated with delay. These results can be used to customize future public health efforts to encourage early presentation for older adults with AMI.
背景/目的:及时给予抗缺血治疗可改善急性心肌梗死(AMI)患者的预后。既往关于AMI治疗延迟的文献主要关注院内延迟(“门球时间”)。我们的目的是确定当代全国老年AMI患者队列中与院前延迟相关的因素。
对急性心肌梗死老年患者综合危险因素评估(SILVER-AMI)研究的数据进行横断面分析,该研究是一项对因AMI住院的老年人进行的观察性研究。
美国学术和社区医院(N = 94)。
因AMI住院的75岁及以上个体(N = 2500)。
院前延迟定义为入院前症状持续时间达6小时或更长,通过AMI住院期间参与者或照顾者报告获得。通过首次住院期间的面对面评估和病历摘要获取来自人口统计学、临床表现、合并症、功能和社会支持领域的延迟潜在预测因素。
非白人种族(调整优势比[aOR]=1.54,P = 0.002)、非典型症状(aOR = 1.41,P = 0.001)和心力衰竭(HF)(HF的aOR = 1.35,P = 0.006)与延迟显著相关。
与年轻AMI人群不同,在这个老年队列中,女性和糖尿病与延迟无关,但其他领域的因素(非白人种族、非典型症状和HF)与延迟显著相关。这些结果可用于定制未来的公共卫生措施,以鼓励老年AMI患者尽早就诊。